Is OMER Worth Buying in 2026?

Omeros Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Omeros Corporation (OMER) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+12.03% over 10 days); strong 1-year return of +330.1%; 3-month momentum positive (+68.2%); rising volume confirms the move (1.65x 30d avg). Concerns: RSI 92 — overbought, elevated pullback risk. Currently 1.6% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

OMER is in a confirmed uptrend, trading above both its 50-day ($11.72) and 200-day ($11.55) moving averages. With an RSI of 92.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +330.1% compares to +20.5% for SPY (beat the market by 309.6%).

$10,000 invested 1 year ago → $43,013 today
vs. S&P 500 (SPY) — same period beat market by 309.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($11.55)
✓Above 50-day MA ($11.72)
!RSI(14) neutral zone (30–70) — currently 92.0
✓Positive return (+330.1%)
✓Within 10% of period high (−1.6%)
Period Range $19.27
$3.94 $19.58
RSI (14) 92.0
0 · OversoldOverbought · 100

Key Metrics

Price$19.27
Period Return+330.1%
Period High$19.58
Period Low$3.94
Drawdown−1.6%
MA-50$11.72
MA-200$11.55
RSI (14)92.0
Avg Volume (30d)2.1M
vs. SPYbeat by 309.6%
Return Rank#31 of 999

Trade OMER

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers